Coverage
-
March 21, 2023
AbbVie Inc. has agreed to pay $2.7 million to settle a whistleblower False Claims Act lawsuit accusing it of using unlawful kickbacks to encourage medical providers to prescribe its blockbuster drug Humira, according to a Tuesday filing in Illinois federal court.
4 other articles on this case.
View all »